Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Trenkwalder

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Sleep Medicine|September 7, 2010
Loss of response during long-term treatment of restless legs syndrome: guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trialsD Garcia-Borreguero, R Allen, R Kohnen, et al.
Annals of Neurology|December 1, 1992
Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's diseaseW H Oertel, K Tatsch, J Schwarz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 15, 2006
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodiesM Bibl, B Mollenhauer, H Esselmann, et al.
Sleep|October 1, 1995
L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trialC Trenkwalder, K Stiasny, T Pollmächer, et al.
Neurology|May 29, 2001
Long-term effects of pergolide in the treatment of restless legs syndromeK Stiasny, T C Wetter, J Winkelmann, et al.
Molecular Psychiatry|March 7, 2007
Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementiasM Bibl, B Mollenhauer, P Lewczuk, et al.
Neurology|April 2, 1999
A randomized controlled study of pergolide in patients with restless legs syndromeT C Wetter, K Stiasny, J Winkelmann, et al.
European Journal of Neurology|March 10, 2018
Pain in Parkinson's disease: facts and uncertaintiesA Antonini, M Tinazzi, G Abbruzzese, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's disease and other basal ganglia disorders"W H Oertel, C Trenkwalder, T Gasser, et al.
Der Nervenarzt|April 28, 2011
[Dementia and depression determine care dependency in Parkinson's disease: analysis of 1,449 outpatients receiving nursing care in Germany]O Riedel, R Dodel, G Deuschl, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Sleep Medicine|September 7, 2010
Loss of response during long-term treatment of restless legs syndrome: guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trialsD Garcia-Borreguero, R Allen, R Kohnen, et al.
Annals of Neurology|December 1, 1992
Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's diseaseW H Oertel, K Tatsch, J Schwarz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 15, 2006
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodiesM Bibl, B Mollenhauer, H Esselmann, et al.
Sleep|October 1, 1995
L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trialC Trenkwalder, K Stiasny, T Pollmächer, et al.
Neurology|May 29, 2001
Long-term effects of pergolide in the treatment of restless legs syndromeK Stiasny, T C Wetter, J Winkelmann, et al.
Molecular Psychiatry|March 7, 2007
Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementiasM Bibl, B Mollenhauer, P Lewczuk, et al.
Neurology|April 2, 1999
A randomized controlled study of pergolide in patients with restless legs syndromeT C Wetter, K Stiasny, J Winkelmann, et al.
European Journal of Neurology|March 10, 2018
Pain in Parkinson's disease: facts and uncertaintiesA Antonini, M Tinazzi, G Abbruzzese, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's disease and other basal ganglia disorders"W H Oertel, C Trenkwalder, T Gasser, et al.
Der Nervenarzt|April 28, 2011
[Dementia and depression determine care dependency in Parkinson's disease: analysis of 1,449 outpatients receiving nursing care in Germany]O Riedel, R Dodel, G Deuschl, et al.
Pageof 15